SlideShare uma empresa Scribd logo
1 de 22
L. J. SALOMON, Z. ALFIREVIC, V. BERGHELLA, C. BILARDO, E. HERNANDEZ-
ANDRADE, S. L. JOHNSEN, K. KALACHE, K.-Y. LEUNG, G. MALINGER, H. MUNOZ, F.
  PREFUMO, A. TOI and W. LEE on behalf of the ISUOG Clinical Standards Committee
Why ?
•The International Society of Ultrasound in Obstetrics and Gynecology
(ISUOG) is a scientific organization that encourages sound clinical practice,
teaching and research for diagnostic imaging in women’s healthcare.
•Practice Guidelines and Consensus are intended to reflect what is
considered by ISUOG to be the best practices at the time at which they
were issued.
•Although ISUOG has made every effort to ensure that guidelines are
accurate when issued, neither the Society nor any of its employees or
members accepts any liability for the consequences of any inaccurate or
misleading data, opinions or statements issued by the CSC.
•Guidelines are not intended to establish a legal standard of care because
interpretation of the evidence that underpins the guidelines may be
influenced by individual circumstances and available resources.
•Approved guidelines can be distributed freely with the permission of ISUOG
(info@isuog.org).
What is the purpose of a mid-trimester
                 fetal ultrasound scan?
•Provide accurate diagnostic information for the delivery of optimized
antenatal care with the best possible outcomes for mother and fetus.
•The procedure is used to determine gestational age and to perform fetal
measurements for the timely detection of are to detect congenital
malformations and multiple pregnancies.
•Prenatal screening examination includes an evaluation of the following:
cardiac activity; fetal number (and chorionicity if multiple pregnancy); fetal
age/size; basic fetal anatomy; placental appearance and location.
•Although many malformations can be identified, it is acknowledged that
some may be missed, even with sonographic equipment in the best of
hands, or that they may develop later in pregnancy.
•Before starting the examination, a healthcare practitioner should counsel
the woman/couple regarding the potential benefits and limitations of a
routine mid-trimester fetal ultrasound scan.
Who should perform the scan?
•In order to achieve optimal results from routine screening examinations, it is
suggested that scans should be performed by individuals who fulfil the
following criteria:
    –trained in the use of diagnostic ultrasonography and related safety issues;
    –regularly perform fetal ultrasound scans;
    –participate in continuing medical education activities;
    –have established appropriate referral patterns for suspicious or abnormal
    findings;
    –routinely undertake quality assurance and control measures.
•If the examination cannot be performed completely in accordance with
adopted guidelines, the scan should be repeated, at least in part, at a later
time, or the patient can be referred to another practitioner. This should be
done as soon as possible, to minimize unnecessary patient anxiety and
unnecessary delay in the potential diagnosis of congenital anomalies or
growth disturbances.
What equipment?
•For routine screening, equipment should have at least the following:
    – real time, gray-scale ultrasound capabilities;
    – transabdominal transducers (3–5-MHz range);
    – adjustable acoustic power output controls with output display
    standards;
    – freeze frame capabilities;
    – electronic calipers;
    – capacity to print/store images;
    – regular maintenance and servicing, important for optimal equipment
    performance.
What document?
•An examination report should be produced as an electronic and/or a
paper document, to be sent to the referring care provider in
reasonable time. A sample reporting form is available at the end of
this guidelines.
•Images of standard views (stored either electronically or as printed
copies) should also be produced and stored. Motion videoclips are
recommended for the fetal heart.
•Local laws should be followed. Many jurisdictions require image
storage for a defined period of time.
Is prenatal ultrasonography safe?

•Prenatal ultrasonography appears to be safe for clinical
practice.
•To date, there has been no independently confirmed study to
suggest otherwise.
•Fetal exposure times should be minimized, using the lowest
possible power output needed to obtain diagnostic
information,
•following the ALARA principle (As Low As Reasonably
Achievable).
•More details are available from the ISUOG Safety Statement.
Well being?
•Amniotic fluid assessment:
   – Amniotic fluid volume can be estimated subjectively or using
   sonographic measurements.
   – Subjective estimation is not inferior to the quantitative measurement
   techniques (e.g. deepest pocket, amniotic fluid index) when performed
   by experienced examiners.
•Fetal movement:
   – Normal fetuses typically have a relaxed position and show regular
   movements.
   – There are no specific movement and temporary absence or
   reduction of fetal movements during the scan should not be considered
   as a risk factor. Abnormal positioning or unusually restricted or
   persistently absent fetal movements may suggest abnormal fetal
   conditions such as arthrogryposis. The biophysical profile is not
   considered part of a routine mid-trimester scan.
Fetal biometry?
•The following sonographic parameters can be used to estimate
gestational age and for fetal size assessment:
     – biparietal diameter (BPD);
     – head circumference (HC);
     – abdominal circumference (AC) or diameter;
     – femur diaphysis length (FDL).
•Measurements should be performed in a standardized manner on the
basis of strict quality criteria. An audit of results can help to ensure
accuracy of techniques with regard to specific reference tables.
•The chosen reference standards should be indicated in the report
•An image(s) should be taken to document the measurement(s).
•The application of Doppler techniques is not currently recommended
as part of the routine second-trimester ultrasound examination. There
is insufficient evidence to support universal use of uterine or umbilical
artery Doppler evaluation for the screening of low-risk pregnancies.
Fetal anatomy?
• Recommended minimum requirements for a basic fetal anatomical
survey during the mid-trimester of pregnancy are summarized in the
report form
• Survey includes:
    – Head: skull, brain..
    – Face
    – Neck
    – Thorax: chest, heart.
    – Abdomen/urinary tract.
    – Skeletal
    – Limbs
    – Placenta, umbilical cord…
Cervix, uterine and adnexa?
• Several studies have demonstrated a strong correlation between
short cervical length on transvaginal scan and subsequent preterm
birth. However, several randomized controlled trials that examined the
combination of routine cervical length measurement and subsequent
interventions (cerclage, progesterone) failed to demonstrate
conclusively any cost-effectiveness of such screening programs.

• Currently, there is insufficient evidence to recommend routine cervical
length measurements at the mid trimester in an unselected population.

• Uterine fibroids and adnexal masses should be documented if they
are likely to interfere with labor.
USE

 THE

FORM!!
ISUOG’s website is a great resource for more information:

Mais conteúdo relacionado

Mais procurados

2nd trimester ultrasound..
2nd trimester ultrasound..2nd trimester ultrasound..
2nd trimester ultrasound..Soumitra Halder
 
Genetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markersGenetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markersMohit Satodia
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILEDrNisheethOza
 
2nd trimester scan
2nd trimester scan2nd trimester scan
2nd trimester scanobsgynhsnz
 
Doppler in gyneacology Dr. Muhammad Bin Zulfiqar
Doppler in gyneacology Dr. Muhammad Bin ZulfiqarDoppler in gyneacology Dr. Muhammad Bin Zulfiqar
Doppler in gyneacology Dr. Muhammad Bin ZulfiqarDr. Muhammad Bin Zulfiqar
 
Usg in third trimester, placenta and amniotic fluid
Usg in third trimester, placenta and amniotic fluidUsg in third trimester, placenta and amniotic fluid
Usg in third trimester, placenta and amniotic fluidDouble M
 
ULTRASOUND IN TWIN PREGNANCY.pptx
ULTRASOUND IN TWIN PREGNANCY.pptxULTRASOUND IN TWIN PREGNANCY.pptx
ULTRASOUND IN TWIN PREGNANCY.pptxAnkitaGoyal72
 
Baseline scan in infertility
Baseline scan in infertilityBaseline scan in infertility
Baseline scan in infertilityPoonam Loomba
 
Basics of tvs color doppler
Basics of tvs color dopplerBasics of tvs color doppler
Basics of tvs color dopplerPoonam Loomba
 
Screening for fetal aneuploidy
Screening for fetal aneuploidyScreening for fetal aneuploidy
Screening for fetal aneuploidyPoonam Loomba
 
Ndvh trips and tricks
Ndvh trips and tricksNdvh trips and tricks
Ndvh trips and tricksManik Gurram
 
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.Abdellah Nazeer
 
Ultrasound markers of aneuploidy
Ultrasound markers of aneuploidyUltrasound markers of aneuploidy
Ultrasound markers of aneuploidyBharath J
 
3D-4D ULTRASOUND IN UTERINE SEPTUM EVALUATION
3D-4D ULTRASOUND  IN UTERINE SEPTUM EVALUATION3D-4D ULTRASOUND  IN UTERINE SEPTUM EVALUATION
3D-4D ULTRASOUND IN UTERINE SEPTUM EVALUATIONNARENDRA MALHOTRA
 
Isuog practice guidelines performance of first trimester fetal ultrasound scan
Isuog practice guidelines performance of first trimester fetal ultrasound scanIsuog practice guidelines performance of first trimester fetal ultrasound scan
Isuog practice guidelines performance of first trimester fetal ultrasound scankaleemullahabid
 

Mais procurados (20)

2nd trimester ultrasound..
2nd trimester ultrasound..2nd trimester ultrasound..
2nd trimester ultrasound..
 
Fetal biometry
Fetal biometry Fetal biometry
Fetal biometry
 
Second trimestric soft markers of aneuploidy
Second trimestric soft markers of aneuploidySecond trimestric soft markers of aneuploidy
Second trimestric soft markers of aneuploidy
 
ISUOG Practice Guidelines: Use of Doppler ultrasonography in obstetrics
ISUOG Practice Guidelines: Use of Doppler ultrasonography in obstetricsISUOG Practice Guidelines: Use of Doppler ultrasonography in obstetrics
ISUOG Practice Guidelines: Use of Doppler ultrasonography in obstetrics
 
Genetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markersGenetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markers
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
 
2nd trimester scan
2nd trimester scan2nd trimester scan
2nd trimester scan
 
Doppler in gyneacology Dr. Muhammad Bin Zulfiqar
Doppler in gyneacology Dr. Muhammad Bin ZulfiqarDoppler in gyneacology Dr. Muhammad Bin Zulfiqar
Doppler in gyneacology Dr. Muhammad Bin Zulfiqar
 
Usg in third trimester, placenta and amniotic fluid
Usg in third trimester, placenta and amniotic fluidUsg in third trimester, placenta and amniotic fluid
Usg in third trimester, placenta and amniotic fluid
 
ULTRASOUND IN TWIN PREGNANCY.pptx
ULTRASOUND IN TWIN PREGNANCY.pptxULTRASOUND IN TWIN PREGNANCY.pptx
ULTRASOUND IN TWIN PREGNANCY.pptx
 
Baseline scan in infertility
Baseline scan in infertilityBaseline scan in infertility
Baseline scan in infertility
 
Imaging for the Diagnosis of ENdometriosis
Imaging for the Diagnosis of ENdometriosisImaging for the Diagnosis of ENdometriosis
Imaging for the Diagnosis of ENdometriosis
 
Basics of tvs color doppler
Basics of tvs color dopplerBasics of tvs color doppler
Basics of tvs color doppler
 
Ultrasound evaluation of fetal thorax
Ultrasound evaluation of fetal thoraxUltrasound evaluation of fetal thorax
Ultrasound evaluation of fetal thorax
 
Screening for fetal aneuploidy
Screening for fetal aneuploidyScreening for fetal aneuploidy
Screening for fetal aneuploidy
 
Ndvh trips and tricks
Ndvh trips and tricksNdvh trips and tricks
Ndvh trips and tricks
 
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.
Presentation1.pptx, ultrasound examination of the 2nd & 3rd trimester pregnancy.
 
Ultrasound markers of aneuploidy
Ultrasound markers of aneuploidyUltrasound markers of aneuploidy
Ultrasound markers of aneuploidy
 
3D-4D ULTRASOUND IN UTERINE SEPTUM EVALUATION
3D-4D ULTRASOUND  IN UTERINE SEPTUM EVALUATION3D-4D ULTRASOUND  IN UTERINE SEPTUM EVALUATION
3D-4D ULTRASOUND IN UTERINE SEPTUM EVALUATION
 
Isuog practice guidelines performance of first trimester fetal ultrasound scan
Isuog practice guidelines performance of first trimester fetal ultrasound scanIsuog practice guidelines performance of first trimester fetal ultrasound scan
Isuog practice guidelines performance of first trimester fetal ultrasound scan
 

Semelhante a ISUOG Mid-trimester Guidelines

Guía ISUOG sobre ecografía del segundo trimestre
Guía ISUOG sobre ecografía del segundo trimestreGuía ISUOG sobre ecografía del segundo trimestre
Guía ISUOG sobre ecografía del segundo trimestreTony Terrones
 
Focused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) guidelineFocused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) guidelineVõ Tá Sơn
 
Ultrasound evaluation of pediatric orthopaedic patient
Ultrasound evaluation of pediatric orthopaedic patientUltrasound evaluation of pediatric orthopaedic patient
Ultrasound evaluation of pediatric orthopaedic patientBipulBorthakur
 
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...Jackie Taylor
 
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...د حاتم البيطار
 
Gene screen technology
Gene screen technologyGene screen technology
Gene screen technologyMiriya Johnson
 
Ultrasonography in pregnancy, acoh 2011.
Ultrasonography in pregnancy, acoh 2011.Ultrasonography in pregnancy, acoh 2011.
Ultrasonography in pregnancy, acoh 2011.goedisoto
 
Pediatric radiology
Pediatric radiologyPediatric radiology
Pediatric radiologyairwave12
 
Perinatal hdn f recovered file 1
Perinatal hdn f recovered file 1 Perinatal hdn f recovered file 1
Perinatal hdn f recovered file 1 Praveen Ganji
 
DIAGNOSIS MODALITIES OF PREGNANCY.pptx
DIAGNOSIS MODALITIES OF PREGNANCY.pptxDIAGNOSIS MODALITIES OF PREGNANCY.pptx
DIAGNOSIS MODALITIES OF PREGNANCY.pptxRameeThj
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
 
Obstetrical ultrasound
Obstetrical ultrasoundObstetrical ultrasound
Obstetrical ultrasoundYogesh Patel
 
7 non invasive & invasive
7 non invasive & invasive7 non invasive & invasive
7 non invasive & invasiveKHUSHBU PATEL
 
assessment of growth and development.pptx
assessment of growth and development.pptxassessment of growth and development.pptx
assessment of growth and development.pptxNithinKumar188
 
Quality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptxQuality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptxmosemsilawy
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)NHSNWRD
 
Screening when where why
Screening when where why Screening when where why
Screening when where why Kawita Bapat
 

Semelhante a ISUOG Mid-trimester Guidelines (20)

Guía ISUOG sobre ecografía del segundo trimestre
Guía ISUOG sobre ecografía del segundo trimestreGuía ISUOG sobre ecografía del segundo trimestre
Guía ISUOG sobre ecografía del segundo trimestre
 
Focused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) guidelineFocused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) guideline
 
Ultrasound evaluation of pediatric orthopaedic patient
Ultrasound evaluation of pediatric orthopaedic patientUltrasound evaluation of pediatric orthopaedic patient
Ultrasound evaluation of pediatric orthopaedic patient
 
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...
Audiologic Guidelines For The Assessment Of Hearing In Infants And Young Chil...
 
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...
د حاتم البيطار استشاري وجراح الفم والاسنان 01005684344 اتصل للحجز بالعيادة مح...
 
sonar _dr hatemelbitar00201005684344.pdf
sonar _dr hatemelbitar00201005684344.pdfsonar _dr hatemelbitar00201005684344.pdf
sonar _dr hatemelbitar00201005684344.pdf
 
Gene screen technology
Gene screen technologyGene screen technology
Gene screen technology
 
Ultrasonography in pregnancy, acoh 2011.
Ultrasonography in pregnancy, acoh 2011.Ultrasonography in pregnancy, acoh 2011.
Ultrasonography in pregnancy, acoh 2011.
 
Pediatric radiology
Pediatric radiologyPediatric radiology
Pediatric radiology
 
Screening
ScreeningScreening
Screening
 
Perinatal hdn f recovered file 1
Perinatal hdn f recovered file 1 Perinatal hdn f recovered file 1
Perinatal hdn f recovered file 1
 
DIAGNOSIS MODALITIES OF PREGNANCY.pptx
DIAGNOSIS MODALITIES OF PREGNANCY.pptxDIAGNOSIS MODALITIES OF PREGNANCY.pptx
DIAGNOSIS MODALITIES OF PREGNANCY.pptx
 
Radiation dose and pregnancy
Radiation dose and pregnancyRadiation dose and pregnancy
Radiation dose and pregnancy
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Obstetrical ultrasound
Obstetrical ultrasoundObstetrical ultrasound
Obstetrical ultrasound
 
7 non invasive & invasive
7 non invasive & invasive7 non invasive & invasive
7 non invasive & invasive
 
assessment of growth and development.pptx
assessment of growth and development.pptxassessment of growth and development.pptx
assessment of growth and development.pptx
 
Quality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptxQuality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptx
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)
 
Screening when where why
Screening when where why Screening when where why
Screening when where why
 

Último

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 

Último (20)

Epilepsy
EpilepsyEpilepsy
Epilepsy
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 

ISUOG Mid-trimester Guidelines

  • 1. L. J. SALOMON, Z. ALFIREVIC, V. BERGHELLA, C. BILARDO, E. HERNANDEZ- ANDRADE, S. L. JOHNSEN, K. KALACHE, K.-Y. LEUNG, G. MALINGER, H. MUNOZ, F. PREFUMO, A. TOI and W. LEE on behalf of the ISUOG Clinical Standards Committee
  • 2. Why ? •The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a scientific organization that encourages sound clinical practice, teaching and research for diagnostic imaging in women’s healthcare. •Practice Guidelines and Consensus are intended to reflect what is considered by ISUOG to be the best practices at the time at which they were issued. •Although ISUOG has made every effort to ensure that guidelines are accurate when issued, neither the Society nor any of its employees or members accepts any liability for the consequences of any inaccurate or misleading data, opinions or statements issued by the CSC. •Guidelines are not intended to establish a legal standard of care because interpretation of the evidence that underpins the guidelines may be influenced by individual circumstances and available resources. •Approved guidelines can be distributed freely with the permission of ISUOG (info@isuog.org).
  • 3.
  • 4. What is the purpose of a mid-trimester fetal ultrasound scan? •Provide accurate diagnostic information for the delivery of optimized antenatal care with the best possible outcomes for mother and fetus. •The procedure is used to determine gestational age and to perform fetal measurements for the timely detection of are to detect congenital malformations and multiple pregnancies. •Prenatal screening examination includes an evaluation of the following: cardiac activity; fetal number (and chorionicity if multiple pregnancy); fetal age/size; basic fetal anatomy; placental appearance and location. •Although many malformations can be identified, it is acknowledged that some may be missed, even with sonographic equipment in the best of hands, or that they may develop later in pregnancy. •Before starting the examination, a healthcare practitioner should counsel the woman/couple regarding the potential benefits and limitations of a routine mid-trimester fetal ultrasound scan.
  • 5. Who should perform the scan? •In order to achieve optimal results from routine screening examinations, it is suggested that scans should be performed by individuals who fulfil the following criteria: –trained in the use of diagnostic ultrasonography and related safety issues; –regularly perform fetal ultrasound scans; –participate in continuing medical education activities; –have established appropriate referral patterns for suspicious or abnormal findings; –routinely undertake quality assurance and control measures. •If the examination cannot be performed completely in accordance with adopted guidelines, the scan should be repeated, at least in part, at a later time, or the patient can be referred to another practitioner. This should be done as soon as possible, to minimize unnecessary patient anxiety and unnecessary delay in the potential diagnosis of congenital anomalies or growth disturbances.
  • 6. What equipment? •For routine screening, equipment should have at least the following: – real time, gray-scale ultrasound capabilities; – transabdominal transducers (3–5-MHz range); – adjustable acoustic power output controls with output display standards; – freeze frame capabilities; – electronic calipers; – capacity to print/store images; – regular maintenance and servicing, important for optimal equipment performance.
  • 7. What document? •An examination report should be produced as an electronic and/or a paper document, to be sent to the referring care provider in reasonable time. A sample reporting form is available at the end of this guidelines. •Images of standard views (stored either electronically or as printed copies) should also be produced and stored. Motion videoclips are recommended for the fetal heart. •Local laws should be followed. Many jurisdictions require image storage for a defined period of time.
  • 8. Is prenatal ultrasonography safe? •Prenatal ultrasonography appears to be safe for clinical practice. •To date, there has been no independently confirmed study to suggest otherwise. •Fetal exposure times should be minimized, using the lowest possible power output needed to obtain diagnostic information, •following the ALARA principle (As Low As Reasonably Achievable). •More details are available from the ISUOG Safety Statement.
  • 9.
  • 10. Well being? •Amniotic fluid assessment: – Amniotic fluid volume can be estimated subjectively or using sonographic measurements. – Subjective estimation is not inferior to the quantitative measurement techniques (e.g. deepest pocket, amniotic fluid index) when performed by experienced examiners. •Fetal movement: – Normal fetuses typically have a relaxed position and show regular movements. – There are no specific movement and temporary absence or reduction of fetal movements during the scan should not be considered as a risk factor. Abnormal positioning or unusually restricted or persistently absent fetal movements may suggest abnormal fetal conditions such as arthrogryposis. The biophysical profile is not considered part of a routine mid-trimester scan.
  • 11. Fetal biometry? •The following sonographic parameters can be used to estimate gestational age and for fetal size assessment: – biparietal diameter (BPD); – head circumference (HC); – abdominal circumference (AC) or diameter; – femur diaphysis length (FDL). •Measurements should be performed in a standardized manner on the basis of strict quality criteria. An audit of results can help to ensure accuracy of techniques with regard to specific reference tables. •The chosen reference standards should be indicated in the report •An image(s) should be taken to document the measurement(s). •The application of Doppler techniques is not currently recommended as part of the routine second-trimester ultrasound examination. There is insufficient evidence to support universal use of uterine or umbilical artery Doppler evaluation for the screening of low-risk pregnancies.
  • 12.
  • 13. Fetal anatomy? • Recommended minimum requirements for a basic fetal anatomical survey during the mid-trimester of pregnancy are summarized in the report form • Survey includes: – Head: skull, brain.. – Face – Neck – Thorax: chest, heart. – Abdomen/urinary tract. – Skeletal – Limbs – Placenta, umbilical cord…
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Cervix, uterine and adnexa? • Several studies have demonstrated a strong correlation between short cervical length on transvaginal scan and subsequent preterm birth. However, several randomized controlled trials that examined the combination of routine cervical length measurement and subsequent interventions (cerclage, progesterone) failed to demonstrate conclusively any cost-effectiveness of such screening programs. • Currently, there is insufficient evidence to recommend routine cervical length measurements at the mid trimester in an unselected population. • Uterine fibroids and adnexal masses should be documented if they are likely to interfere with labor.
  • 20.
  • 22. ISUOG’s website is a great resource for more information: